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Abstract
Background: Premature ovarian failure (POF) is a complex and heterogeneous disorder that is influenced by
multiple genetic components. Numerous candidate gene studies designed to identify POF susceptibility loci have
been published, but most positive findings have not been confirmed in follow up studies. We sought to determine
if sequence variants previously associated with age at natural menopause (AANM) or early menopause (EM)
contribute as well to genetic susceptibility to POF.
Methods: Our study was performed on 371 unrelated idiopathic women with POF and 800 women controls, all
Chinese Han. Thirty six SNPs from previous genome-wide association studies (GWAS) responsible for AANM or EM
and 3 additional SNPs in ESR1, and 2 additional SNPs in PTHB1 were tested using the Sequenom MassARRAY iPLEX
platform for genotyping.
Results: Three SNPs - rs2278493 in HK3, rs2234693 in ESR1 and rs12611091 in BRSK1 - showed nominally
significant association with POF. Thus, a plausible relationship could exist between ESR1, BRSK1, HK3 and POF.
Conclusions: This largest association study undertaken to determine correlation between POF and AANM/EM
revealed three significant SNPs (rs2278493, rs2234693, and rs12611091). All are associated with not only AAWM and
EM but also POF. Insights into shared genetic susceptibility between POF and AANM/EM will provide novel entry
points for unraveling genetic mechanism involved in ovarian reserve and oocyte aging processes.
Keywords: Premature ovarian failure (POF), Primary ovarian insufficiency (POI), Age at natural menopause (AANM),
HK3, ESR1, BRSK1, Premature menopause, Hypergonadotropic hypogonadism
Background
Natural menopause is one of the most important physio-
logical events, the cessation of ovarian function and the
end of the reproductive lifespan. Twin and family studies
indicate high heritability for age at natural menopause
(AANM) (49-87%) [1]. The AANM in Chinese women is
approximately 49 years [2]. Early onset of menopause
increases risk for many postmenopausal health complica-
tions. Menopause occurring between 40 and 44 years has
an incidence of 5% and is termed early menopause (EM)
[3]. Premature ovarian failure (POF), also termed as pri-
mary ovarian insufficiency (POI), is defined as ovarian
failure before the age 40 years [4,5].
POF is characterized by secondary amenorrhea, hypoes-
trogenism and elevated gonadotropin serum levels (FSH >
40 IU/L). Approximately 1% of the population has POF
before age 40 years; only 0.1% or less are affected prior to
age 30. Although most cases of POF occur sporadically,
approximately 10 - 15% of cases have an affected first-
degree relative [6]. Based on either known roles in follicu-
logenesis or phenotypes of murine knockout models,
many candidate genes have been interrogated to deter-
mine their role in POF. However, except for FSHR in
Finnish women none explains more than 1-2% of POF in
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cause POF have nonetheless been identified in single
patients or families, small patient groups or selected ethnic
groups. This may reflect genetic heterogeneity, ethnic-spe-
cific genetic variation or failure to interrogate sufficient
numbers of the candidate genes that could potentially
account for POF.
Via genome-wide association studies (GWASs), it is pos-
sible to identify common genetic variants contributing to
susceptibility to genetically complex or polygenic diseases.
Despite the attractiveness of GWAS for POF, genome
searches in a sufficiently large number of patients are
practically absent [8]. Kang H.J. et al. showed association
of two SNPs (rs3884597 and rs6944723) in the PTH-
responsive B1 gene (PTHB1) in a small discovery set of 24
women and 24 controls, followed by confirmation in 101
cases and 87 controls [9]. The other GWAS showed asso-
ciation with ADAMTS19 in the discovery set of 99 Dutch
women and 181 controls, but not in the replication set (60
POF cases and 90 controls) [10]. That 8% of the relatives
of women with POF in Chinese suffer from either early
menopause or POF (Table 1) suggests an interrelated
genetic mechanism between POF and early menopause.
Indeed, Tibiletti et al. proposed that POF and EM patients
share similar genetic features and postulated that these
conditions may be a variable expression of the same
genetic disease [11]. Additionally, FMR1 is a single gene
cause of POF, and it is clinically indicated to test for pre-
mutation in this gene. Genes like EIF2B5 and FMR1 that
are known to be involved in POF have been reported to be
associated also with AANM [12-14]. Few studies have
explored the shared genetic associations among POF,
AANM and EM. On the basis of four independent
GWAS, 36 SNPs have been associated with AANM. These
are located on chromosomes 2, 3, 5, 6, 7, 8, 9, 11, 12, 13,
15, 18, 19 and 20, respectively, with robust statistical evi-
dence. Of these, 2 SNPs were related to EM [1,15,16].
Besides these 36 SNPs, we also assessed correlation
between POF and three additional SNPs in the estrogen
receptor 1 (ESR1) gene, given the key role of ER-a in folli-
culogenesis. ESR1 has also been considered a promising
candidate gene for POF, with rs2234693, rs9340799 and
rs1569788 of ESR1 reported to be associated with idio-
pathic POF [17-19]. ESR1 also has been one of the most
popular candidates related with AANM in previous asso-
ciation studies [20,21].
Overall, we sought to determine the contribution to
POF of the 36 SNPs from AANM GWAS, the 3 SNPs
in the ESR1 gene and the 2 SNPs in the PTHB1 gene.
Our association study involved 371 women with POF
and 800 controls, all Chinese Han.
Methods
Participants and phenotypes
Our study was performed on 371 unrelated idiopathic
women with POF and 800 women controls, all Chinese
Han, collectively gathered from a number of high
volume regional referral centers in China. Samples were
collected from 18 provinces during 2002-2010. The age
of secondary amenorrhea in our sample was young
Table 1 Clinical features of cases and controls, which are not significantly different (p > 0.05).
Characteristic
Cases
Number 371
FSH concentration (IU/L)
a 73.88 ± 30.23
Familial clustering
b 32
Mother affected 27
Menopause < 40 yrs 13
40 yrs < Menopause < 45 yrs 14
Siblings affected 5
Menopause < 40 yrs 5
Age at diagnosis (yrs)
a 29.79 ± 5.31
Amenorrhea Secondary 228
Age at menarche (yrs)
a 14.82 ± 2.11
Age at onset of menstrual dysfunction (yrs)
a 23.85 ± 6.78
Age at amenorrhea (yrs)
a 24.87 ± 5.88
Controls
Number 800
Age(yrs)
a at sample 38.77 ± 11.58
Age at menarche(yrs)
a 14.75 ± 1.45
a ±S D
b Defined as two or more first-or second-degree female family members with either POF or early menopause (less than 45 years old), including the index POF
patient.
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Page 2 of 6(mean age 23.85 ± 6.78 years) (Table 1). 8% (32/400) of
cases had a positive family history, i.e., at least two first-
or second-degree female family members with POF or
early menopause including the index POF patient. Most
of the affected relatives (27/32; thirteen < 40 yrs and
fourteen < 45 yrs) were mothers of the index patient;
the remaining five were sisters. Inclusion criteria for
POF consisted of cessation of menstrual cycles before
40 years of age, with at least two serum follicle stimulat-
ing hormone (FSH) concentrations exceeding 40 IU/L.
Serum FSH level was determined by the electrochemilu-
minescent immunoassay in the analyzer cobas e 601
(Roche, Switzerland). The analytical sensitivity of basal
FSH was < 0.10 mIU/ml. All samples were run in the
same assay. Early menopause is defined as menopause
that occurs between ages 40 and 44. Women with
known chromosomal abnormalities, previous ovarian
surgery, chemotherapy, or radiotherapy were excluded.
Controls attended the clinic because of tubal factor
infertility. They were known to be menstruating regu-
larly and confirmed by hormone assays (< 40 mIU/L)
and ultrasound imaging to be free of POF-related and
early menopause- related phenotypes. Informed consent
was obtained from all subjects. The study was approved
by the Institutional Review Board of Reproductive Medi-
cine of Shandong University.
Genotyping and statistical analysis
SNPs were chosen for genotyping on the basis of published
findings in association studies. A total of 41 SNPs are
located in LHCGR, PPARG, SRD5A1, HK3, RAP80,
SYCP2L, TNF, ESR1, IGF2R, PTHB1, NBN, TGFBR1,
F S H B ,P G R ,A N K K 1 ,I G F 1 ,C Y P 1 9 A 1 ,P O L G ,S M A D 7 ,
BRSK1, TMEM150B, MCM8 or intergenic region (Table 2).
We used the Sequenom MassARRAY iPLEX platform for
genotyping. The Sequenom protocol involves a multiplex
PCR reaction prior to a single-base primer extension reac-
tion. The individual SNPs are identified by using matrix-
assisted laser desorption/ionization time- of- fight mass
spectrometry. SNPs were excluded if the minor allele fre-
quency was < 1%. Ultimately, 36 SNPs were genotyped in
the case control cohort. Allelic association analysis was con-
ducted using SHEsis [22]. The genotype distributions for all
SNPs were tested for Hardy-Weinberg equilibrium (HWE)
using the Fisher’s exact test. All SNPs were in Hardy- Wein-
berg equilibrium. The allelic odds ratio (OR) and 95% confi-
dence interval (CI) were estimated assuming a
multiplicative model. P-values were two-tailed. An alpha of
0.05 was used to claim statistical significance.
Results
We analyzed 41 SNPs for association with POF in our
collection of 400 cases and 800 controls. The analysis
was nominally significant for three SNPs: rs2278493 in
HK3, rs2234693 in ESR1 and rs12611091 in BRSK1,
respectively. Results are summarized in Table 2. These
findings demonstrate that certain SNPs associated with
AANM also may contribute to POF, but need not neces-
sarily play a major role in POF. No significant association
with POF was observed for the remaining 38 SNPs.
Discussion
We conducted the largest association study reported to
date in a POF cohort in order to test the contribution to
POF of 36 SNPs, specifically known to be associated with
AANM and EM. We also investigated the associations of
3 ESR1 SNPs and 2 PTHB1 SNPs in POF. We found con-
tribution to POF for SNPs in ESR1, BRSK1 and HK3, 2 of
these genes not previously considered as candidates for
POF.
Estrogen regulates cyclic gonadotropin release at the
hypothalamus- hypophysis- ovarian (HPO) axis by the
estrogen receptor a (ER-a), which is encoded by ESR1
and enhances follicular development by the ER-b encoded
by ESR2. Female ER-a knockout mice show anovulation
and complete infertility. Rs2234693 lies in an intron of the
ESR1gene and has been reported to be related to POF and
the onset of natural menopause in Korean and Dutch
[17-19], consistent with our results. Because this SNP does
not change any amino acid in the ERS1 protein, it is pre-
sumed to be in linkage disequilibrium with a regulatory
sequence(s) that could affect gene expression or function
and consequently result in an alteration in estrogenic bio-
logical activity.
Rs12611091 is located in the intron region of BRSK1
(BR serine/threonine kinase 1), a gene that codes for an
AMP-activated protein kinase (AMPK)-related kinase [23].
BRSK1 is highly expressed in human brain and moderately
expressed in mammalian ovaries [24]. Mutation or overex-
pression of the BRSK1 gene deleteriously affects vesicle
transport and release at the axon terminals [25]. BRSK1
might affect the secretion of gonadotropin- releasing hor-
mone (GnRH) from the hypothalamus through this
mechanism. Additionally, maternal embryonic leucine zip-
per kinase (MELK), which is highly expressed in spermato-
gonia and oocytes, is one of the downstream targets of
BRSK1 [26,27]. Plausible involvement in ovarian aging is
therefore suggested for BRSK1.
Hexokinase 3 (white cell) (HK3), one of the four hexo-
kinase family members, is involved in carbohydrate meta-
bolism through phosphorylating glucose to produce
glucose-6-phosphate [28]. HK3 is present in uterus, pla-
centa, lung and adipose according to GeneAtlas [24]. Lit-
erature analysis for HK3 did not indicate an immediate
functional explanation for the observed association. To
elucidate the precise molecular mechanism, extensive
sequence analysis and functional studies of the HK3gene
variants are needed.
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onset and have long been considered to represent
variable expression of the same genetic disease [11]. It
is highly plausible that certain genes might contribute
to both. That is, similar underlying genetic predisposi-
tion exists, possibly with different environmental
factors or modifiers triggering disease progression and,
hence, specific age of onset. Another possibility is that
certain genes in pathways ordinarily predisposing only
to EM interact or converge to cause even earlier age
of onset, i.e, below age 40 and thus lead to clinical
POF.
Table 2 Loci selected for association analysis in POF and controls.
All samples (371 cases and 800 controls) Gene information Phenotype related
CHR BP SNP F_MISS HWE_P A1 F_A F_U A2 P OR
3 12423994 rs4135280 0.008333 0.2789 C 0.2861 0.2738 T 0.5321 1.063 PPARG AANM
5 6692179 rs494958 0.009167 0.3597 T 0.2263 0.2237 A 0.8881 1.015 SRD5A1 AANM
5 176247040 rs2278493 0.008333 0.08305 A 0.3451 0.3881 G 0.0432 0.8309 HK3 AANM
5 176255904 rs691141 0.0175 0.682 T 0.4747 0.4608 C 0.5302 1.057 HK3 AANM
5 176290671 rs7718874 0.01083 0.4156 T 0.4696 0.4765 C 0.7525 0.9726 RAP80 AANM
5 176311180 rs365132 0.0175 0.4133 C 0.4669 0.4744 A 0.7343 0.9704 RAP80 AANM
5 176367046 rs402511 0.01833 0.293 C 0.4707 0.4769 T 0.7792 0.9755 RAP80 AANM
5 176436169 rs244715 0.01083 0.3229 A 0.4842 0.4703 G 0.5254 1.058 intergenic EM
6 11005474 rs2153157 0.0275 0.5569 G 0.3484 0.335 A 0.5233 1.061 SYCP2L AANM
6 31648292 rs909253 0.01333 0.0382 C 0.4134 0.3829 T 0.1564 1.136 TNF AANM
6 152205028 rs2234693 0.01 0.7176 C 0.3655 0.4217 T 0.009057 0.79 ESR1 POF/AANM
6 152205074 rs9340799 0.006667 0.7148 G 0.189 0.2016 A 0.4703 0.9228 ESR1 POF/AANM
6 152370309 rs1569788 0.008333 0.7268 T 0.453 0.474 C 0.338 0.9191 ESR1 POF/AANM
6 160419555 rs2297362 0.008333 0.9062 C 0.4301 0.4383 T 0.7047 0.9669 IGF2R AANM
6 160423646 rs9457827 0.01417 0.9059 T 0.4312 0.4379 C 0.7602 0.9732 IGF2R AANM
7 33351787 rs3884597 0.009167 0.222 T 0.467 0.4784 G 0.6047 0.9554 PTHB1 POF
7 33390485 rs6944723 0.01083 1 A 0.4459 0.4183 T 0.2051 1.119 PTHB1 POF
8 91019056 rs2697679 0.009167 0.5546 G 0.4195 0.437 T 0.4217 0.931 NBN AANM
8 91082415 rs7011299 0.015 0.5509 G 0.4237 0.4202 C 0.8727 1.014 NBN AANM
9 100955986 rs1590 0.0075 0.1803 G 0.4581 0.466 T 0.7184 0.9687 TGFBR1 AANM
11 30196754 rs11031010 0.0125 0.4482 A 0.04319 0.04047 C 0.7559 1.07 FSHB AANM
11 112786283 rs6279 0.0075 0.05507 C 0.4619 0.4747 G 0.5609 0.9501 ANKK1 AANM
13 111017433 rs1361542 0.005833 0.396 A 0.03665 0.03391 G 0.7332 1.084 intergenic AANM
13 111017854 rs1756091 0.006667 0.3965 A 0.03655 0.03461 C 0.8101 1.058 intergenic AANM
13 111019298 rs7333181 0.0075 0.3965 A 0.03655 0.03465 G 0.8143 1.057 intergenic AANM
13 111019632 rs1163623 0.003333 0.3965 C 0.03627 0.03457 T 0.8326 1.051 intergenic AANM
15 49335997 rs11856927 0.005833 0.6833 C 0.4532 0.4641 A 0.6187 0.9572 CYP19A1 AANM
15 87670333 rs2351002 0.01083 0.5205 G 0.3521 0.3398 C 0.5542 1.056 POLG AANM
18 44721958 rs4939833 0.0075 0.1067 G 0.03403 0.04203 A 0.3495 0.803 SMAD7 AANM
19 60492141 rs12611091 0.005833 0.8633 T 0.2422 0.2001 C 0.01892 1.278 BRSK1 AANM
19 60506693 rs1551562 0.01917 0.161 G 0.06016 0.06974 A 0.3858 0.8539 BRSK1 AANM
19 60511657 rs1172822 0.008333 0.384 T 0.0953 0.09046 C 0.7026 1.059 BRSK1 AANM
19 60516144 rs7246479 0.0075 0.4537 C 0.1929 0.1895 A 0.8435 1.022 BRSK1 AANM
19 60523000 rs2384687 0.006667 0.4769 C 0.08877 0.09023 T 0.9072 0.9822 TMEM150B AANM
19 60525476 rs11668344 0.005833 0.4762 C 0.08724 0.08962 T 0.8488 0.9709 TMEM150B AANM
19 60525566 rs897798 0.0075 0.6029 C 0.08924 0.09383 T 0.7183 0.9463 TMEM150B AANM
11 30203352 rs621686 0.01417 1 G 0.002653 0.00062 A 0.1956 4.285 FSHB AANM
11 30218544 rs7951733 0.003333 1 G 0 0.000617 A 0.4899 0 FSHB AANM
11 100477546 rs619487 0.003333 1 C 0.003886 0.006173 A 0.4769 0.6281 PGR AANM
12 101388555 rs1019731 0.0075 1 T 0.002611 0.003094 G 0.8388 0.8435 IGF1 AANM
20 5896227 rs16991615 0.01167 1 A 0.001316 0.001241 G 0.9617 1.061 MCM8 EM
CRH: Chromosome; SNP: Single-nucleotide polymorphism; HWE_P: Hardy-Weinberg principle; F_A, F_U indicate the allele frequency in cases and controls,
respectively
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In summary, our data demonstrate that genetic suscept-
ibility for both AANM/EM and POF is shared by the
ESR1, HK3 and BRSK1 genes. This became evident by
our showing that three SNPs previously related to
AANM were associated with POF. At these newly iden-
tified loci fine mapping or sequencing might lead to
identification of causal variants, and thus expand our
knowledge of the underlying mechanism of POF.
Insights into shared genetic susceptibility between POF
and AANM/EM will further provide novel entry points
for unraveling etiology involved in ovarian reserve and
aging process. Identifying genetic causation may further
be of diagnostic value to other family members, espe-
cially female offspring. If a younger relative has the
same genetic variant, timeline for achieving pregnancy
might be advanced and early child-bearing encouraged.
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